Unique Ingredient Identifier 2165RE0K14 is listed as a unspecified ingredient
| RN | 9004-64-2 |
| NCIT | C80901 |
| RXCUI | 1363584 |
UNII 2165RE0K14 LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | TABLET | 7 mg |
| ORAL | CAPSULE | 5.3 mg |
| ORAL | TABLET, EXTENDED RELEASE | 6.25 mg |
| ORAL | CAPSULE | 35.63 MG |
| ORAL | CAPSULE, DELAYED ACTION | 40 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 20 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 20 MG |
| ORAL | CAPSULE, HARD GELATIN | 6 MG |
| ORAL | TABLET | 100 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 50 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 35 MG |
| ORAL | TABLET, DELAYED ACTION, COATED | 15 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 19.5 MG |
| ORAL | TABLET, DELAYED RELEASE | 26.3 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 63 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 42 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 40 MG |
| ORAL | TABLET, SUSTAINED ACTION | 11.66 MG |